JournalsHub
.online
Find My Journal
VS

Vera J. Suman

Mayo Clinic in Arizona US

ORCID 0000-0002-9640-5189
478
Publications
29,361
Citations
76
H-Index
233
i10-Index
5.81
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer OA
Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer +20 more
New England Journal of Medicine 2005
5,343
Whole-genome analysis informs breast cancer response to aromatase inhibition OA
Matthew J. Ellis, Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman +54 more
Nature 2012
1,028
Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 OA
Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong‐Hyeon Jeong, George W. Sledge +11 more
Journal of Clinical Oncology 2014
990
Benign Breast Disease and the Risk of Breast Cancer OA
Lynn C. Hartmann, Thomas A. Sellers, Marlene H. Frost, Wilma L. Lingle, Amy C. Degnim +12 more
New England Journal of Medicine 2005
933
Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes OA
Matthew P. Goetz, James M. Rae, Vera J. Suman, Stephanie L. Safgren, Matthew M. Ames +8 more
Journal of Clinical Oncology 2005
784

Publications

478 total

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance) PDF

Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Rodrigo Gonçalves, Souzan Sanati et al. - Journal of Clinical Oncology, 2017
Cited by 406 OpenAlex

Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 PDF

Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong‐Hyeon Jeong, George W. Sledge et al. - Journal of Clinical Oncology, 2014
Cited by 990 OpenAlex

Whole-genome analysis informs breast cancer response to aromatase inhibition PDF

Matthew J. Ellis, Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman et al. - Nature, 2012
Cited by 1,028 OpenAlex

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31 PDF

Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong‐Hyeon Jeong, Nancy E. Davidson et al. - Journal of Clinical Oncology, 2011
Cited by 714 OpenAlex

Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Lin Li, Jacqueline Snider et al. - Journal of Clinical Oncology, 2011
Cited by 554 OpenAlex

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study PDF

Keith C. Bible, Vera J. Suman, Julian R. Molina, Robert C. Smallridge, William J. Maples et al. - The Lancet Oncology, 2010
Cited by 414 OpenAlex

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials PDF

Edward L. Korn, Ping-Yu Liu, Sandra J. Lee, J. W. Chapman, Donna Niedzwiecki et al. - Journal of Clinical Oncology, 2008
Cited by 698 OpenAlex

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial PDF

Edith A. Perez, Vera J. Suman, Nancy E. Davidson, George W. Sledge, Peter A. Kaufman et al. - Journal of Clinical Oncology, 2008
Cited by 543 OpenAlex

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

Matthew P. Goetz, Stacey K. Knox, Vera J. Suman, James M. Rae, Stephanie L. Safgren et al. - Breast Cancer Research and Treatment, 2006
Cited by 550 OpenAlex

<i>HER2</i> Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial PDF

Edith A. Perez, Vera J. Suman, Nancy E. Davidson, Silvana Martino, Peter A. Kaufman et al. - Journal of Clinical Oncology, 2006
Cited by 443 OpenAlex

Research Topics

Breast Cancer Treatment Studies (101) Estrogen and related hormone effects (95) Advanced Breast Cancer Therapies (75) HER2/EGFR in Cancer Research (61) Cancer Treatment and Pharmacology (49)

Frequent Co-Authors

ED
Edith A. Perez
6 joint publications
NA
Nancy E. Davidson
5 joint publications
SI
Silvana Martino
5 joint publications
DA
Daniel W. Visscher
5 joint publications
WI
Wilma L. Lingle
5 joint publications
JA
James N. Ingle
5 joint publications

Affiliations

University of North Carolina at Chapel Hill
US 2017 - 2010
University of Southern California
US 2013 - 2013
University of Maryland, Baltimore
US 2012 - 2012
Novartis (Switzerland)
CH 2017 - 2017
Dartmouth–Hitchcock Medical Center
US 2007 - 2004

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now